Zentalis Pharmaceuticals IncNASDAQ:ZNTL
- LAST PRICE3.7300
- TODAY'S CHANGE (%)0.4100 (12.3494%)
- Bid / Lots3.7200/ 2
- Ask / Lots3.9000/ 31
- Open / Previous Close3.2500 / 3.3200
- Day Range
- 52 Week Range
- Volume2,852,471
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ZNTL |
|---|---|---|
| 09:32 ET | 22396 | 3.29 |
| 09:33 ET | 21885 | 3.4 |
| 09:35 ET | 62678 | 3.54 |
| 09:37 ET | 6240 | 3.3201 |
| 09:39 ET | 5940 | 3.39 |
| 09:42 ET | 10474 | 3.37 |
| 09:44 ET | 4052 | 3.345 |
| 09:46 ET | 10234 | 3.3 |
| 09:48 ET | 21068 | 3.2212 |
| 09:50 ET | 9249 | 3.1906 |
| 09:51 ET | 11514 | 3.24 |
| 09:53 ET | 2441 | 3.26 |
| 09:55 ET | 9900 | 3.39 |
| 09:57 ET | 8570 | 3.43 |
| 10:00 ET | 39067 | 3.5003 |
| 10:02 ET | 18956 | 3.525 |
| 10:04 ET | 38882 | 3.585 |
| 10:06 ET | 15200 | 3.59 |
| 10:08 ET | 47070 | 3.6599 |
| 10:09 ET | 8908 | 3.6615 |
| 10:11 ET | 5798 | 3.69 |
| 10:13 ET | 10334 | 3.72 |
| 10:15 ET | 36631 | 3.7112 |
| 10:18 ET | 10630 | 3.685 |
| 10:20 ET | 8802 | 3.665 |
| 10:22 ET | 14070 | 3.73 |
| 10:24 ET | 33279 | 3.815 |
| 10:26 ET | 26607 | 3.86 |
| 10:27 ET | 32487 | 3.8688 |
| 10:29 ET | 39314 | 3.75 |
| 10:31 ET | 22601 | 3.7012 |
| 10:33 ET | 28285 | 3.68 |
| 10:36 ET | 10504 | 3.662 |
| 10:38 ET | 3398 | 3.7 |
| 10:40 ET | 10526 | 3.718 |
| 10:42 ET | 3544 | 3.74 |
| 10:44 ET | 9096 | 3.785 |
| 10:45 ET | 22845 | 3.795 |
| 10:47 ET | 21780 | 3.79 |
| 10:49 ET | 32221 | 3.81 |
| 10:51 ET | 74204 | 3.89 |
| 10:54 ET | 33737 | 3.935 |
| 10:56 ET | 13523 | 3.94 |
| 10:58 ET | 18977 | 3.92 |
| 11:00 ET | 3403 | 3.97 |
| 11:02 ET | 44884 | 4.02 |
| 11:03 ET | 24286 | 3.9907 |
| 11:05 ET | 24827 | 3.995 |
| 11:07 ET | 23704 | 4.005 |
| 11:09 ET | 38079 | 4.0194 |
| 11:12 ET | 62705 | 4.03 |
| 11:14 ET | 13586 | 4.0612 |
| 11:16 ET | 25072 | 4.06 |
| 11:18 ET | 23529 | 4.01 |
| 11:20 ET | 39336 | 3.9404 |
| 11:21 ET | 18521 | 3.9109 |
| 11:23 ET | 38383 | 3.96 |
| 11:25 ET | 1553 | 3.98 |
| 11:27 ET | 8001 | 3.985 |
| 11:30 ET | 46908 | 4.045 |
| 11:32 ET | 24396 | 4.0485 |
| 11:34 ET | 23967 | 4.0299 |
| 11:36 ET | 16079 | 4 |
| 11:38 ET | 9529 | 4.035 |
| 11:39 ET | 11603 | 4.0104 |
| 11:41 ET | 7927 | 4.025 |
| 11:43 ET | 52320 | 3.97 |
| 11:45 ET | 8526 | 3.915 |
| 11:48 ET | 15132 | 3.955 |
| 11:50 ET | 11524 | 3.9 |
| 11:52 ET | 9211 | 3.885 |
| 11:54 ET | 19974 | 3.89 |
| 11:56 ET | 15980 | 3.92 |
| 11:57 ET | 1370 | 3.93 |
| 11:59 ET | 5147 | 3.93 |
| 12:01 ET | 3856 | 3.945 |
| 12:03 ET | 5912 | 3.925 |
| 12:06 ET | 4486 | 3.905 |
| 12:08 ET | 7662 | 3.9412 |
| 12:10 ET | 4500 | 3.94 |
| 12:12 ET | 2749 | 3.955 |
| 12:14 ET | 16081 | 3.92 |
| 12:15 ET | 2354 | 3.94 |
| 12:17 ET | 17342 | 3.92 |
| 12:19 ET | 32940 | 3.82 |
| 12:21 ET | 1394 | 3.8381 |
| 12:24 ET | 10341 | 3.875 |
| 12:26 ET | 3466 | 3.8912 |
| 12:28 ET | 4247 | 3.8753 |
| 12:30 ET | 4672 | 3.855 |
| 12:32 ET | 3123 | 3.87 |
| 12:33 ET | 1200 | 3.87 |
| 12:35 ET | 7685 | 3.88 |
| 12:37 ET | 9791 | 3.8701 |
| 12:39 ET | 750 | 3.8812 |
| 12:42 ET | 6949 | 3.895 |
| 12:44 ET | 3700 | 3.885 |
| 12:46 ET | 2756 | 3.9209 |
| 12:48 ET | 3177 | 3.9088 |
| 12:50 ET | 300 | 3.91 |
| 12:51 ET | 4327 | 3.9 |
| 12:53 ET | 2749 | 3.905 |
| 12:55 ET | 2400 | 3.91 |
| 12:57 ET | 13872 | 3.925 |
| 01:00 ET | 5906 | 3.925 |
| 01:02 ET | 1534 | 3.89 |
| 01:04 ET | 11249 | 3.8612 |
| 01:06 ET | 8182 | 3.86 |
| 01:08 ET | 5687 | 3.87 |
| 01:09 ET | 1284 | 3.855 |
| 01:11 ET | 1847 | 3.8505 |
| 01:13 ET | 1300 | 3.855 |
| 01:15 ET | 1326 | 3.865 |
| 01:18 ET | 6848 | 3.89 |
| 01:20 ET | 400 | 3.89 |
| 01:22 ET | 4588 | 3.87 |
| 01:24 ET | 1594 | 3.865 |
| 01:26 ET | 1500 | 3.865 |
| 01:27 ET | 16432 | 3.9211 |
| 01:29 ET | 7734 | 3.935 |
| 01:31 ET | 8293 | 3.935 |
| 01:33 ET | 4302 | 3.9594 |
| 01:36 ET | 2526 | 3.955 |
| 01:38 ET | 27181 | 3.975 |
| 01:40 ET | 9690 | 3.97 |
| 01:42 ET | 4032 | 3.965 |
| 01:44 ET | 4271 | 3.975 |
| 01:45 ET | 1996 | 3.9412 |
| 01:47 ET | 6703 | 3.975 |
| 01:49 ET | 11287 | 3.9611 |
| 01:51 ET | 16297 | 3.915 |
| 01:54 ET | 1750 | 3.925 |
| 01:56 ET | 3688 | 3.8988 |
| 01:58 ET | 3799 | 3.875 |
| 02:00 ET | 11870 | 3.89 |
| 02:02 ET | 2542 | 3.905 |
| 02:03 ET | 1300 | 3.915 |
| 02:05 ET | 3010 | 3.905 |
| 02:07 ET | 100 | 3.91 |
| 02:09 ET | 4043 | 3.895 |
| 02:12 ET | 1964 | 3.905 |
| 02:14 ET | 6368 | 3.905 |
| 02:16 ET | 502 | 3.9088 |
| 02:18 ET | 11113 | 3.92 |
| 02:20 ET | 2698 | 3.915 |
| 02:21 ET | 3943 | 3.945 |
| 02:23 ET | 2157 | 3.94 |
| 02:25 ET | 7137 | 3.955 |
| 02:27 ET | 7493 | 3.945 |
| 02:30 ET | 6430 | 3.925 |
| 02:32 ET | 5224 | 3.9089 |
| 02:34 ET | 5965 | 3.915 |
| 02:36 ET | 5033 | 3.915 |
| 02:38 ET | 2017 | 3.92 |
| 02:39 ET | 4948 | 3.895 |
| 02:41 ET | 10396 | 3.8748 |
| 02:43 ET | 3350 | 3.865 |
| 02:45 ET | 2485 | 3.87 |
| 02:48 ET | 6871 | 3.89 |
| 02:50 ET | 7924 | 3.865 |
| 02:52 ET | 1268 | 3.8612 |
| 02:54 ET | 4389 | 3.859 |
| 02:56 ET | 2815 | 3.87 |
| 02:57 ET | 8877 | 3.9 |
| 02:59 ET | 4900 | 3.879 |
| 03:01 ET | 4148 | 3.875 |
| 03:03 ET | 5437 | 3.885 |
| 03:06 ET | 4897 | 3.885 |
| 03:08 ET | 1676 | 3.89 |
| 03:10 ET | 7445 | 3.885 |
| 03:12 ET | 7128 | 3.875 |
| 03:14 ET | 2189 | 3.88 |
| 03:15 ET | 2724 | 3.875 |
| 03:17 ET | 7117 | 3.84 |
| 03:19 ET | 2500 | 3.835 |
| 03:21 ET | 16652 | 3.815 |
| 03:24 ET | 750 | 3.82 |
| 03:26 ET | 5075 | 3.83 |
| 03:28 ET | 3593 | 3.83 |
| 03:30 ET | 24293 | 3.795 |
| 03:32 ET | 5949 | 3.825 |
| 03:33 ET | 4261 | 3.84 |
| 03:35 ET | 8027 | 3.845 |
| 03:37 ET | 5190 | 3.835 |
| 03:39 ET | 7332 | 3.825 |
| 03:42 ET | 5506 | 3.815 |
| 03:44 ET | 11738 | 3.83 |
| 03:46 ET | 8644 | 3.835 |
| 03:48 ET | 27752 | 3.845 |
| 03:50 ET | 20883 | 3.795 |
| 03:51 ET | 20461 | 3.805 |
| 03:53 ET | 15133 | 3.795 |
| 03:55 ET | 31056 | 3.765 |
| 03:57 ET | 26195 | 3.765 |
| 04:00 ET | 186202 | 3.73 |
Nov 1, 2024
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 7:04PM ET on Friday Nov 01, 2024 by Dow Jones
7:04PM ET on Friday Nov 01, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Zentalis Pharmaceuticals Inc | 236.1M | -1.4x | --- |
Omeros Corp | 236.4M | -1.3x | --- |
Compass Therapeutics Inc. | 233.9M | -4.8x | --- |
aTyr Pharma Inc | 230.4M | -3.4x | --- |
Nkarta Inc | 225.1M | -1.6x | --- |
Acrivon Therapeutics Inc | 248.1M | -2.8x | --- |
Company Information
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. The Company’s lead product candidate includes azenosertib (ZN-c3), which is a WEE1 inhibitor for advanced solid tumors and hematological malignancies. The Company is also developing a BCL-2 inhibitor, ZN-d5, for hematological malignancies and related disorders. ZN-d5 is being evaluated in combination with azenosertib in a Phase I/II dose escalation clinical trial in patients with R/R acute myeloid leukemia (AML) (ZN-d5-004C). The Company is also advancing its research on protein degraders and other undisclosed targets using its Integrated Discovery Engine.
Contact Information
- Headquarters
- 10275 Science Center Drive, Suite 200SAN DIEGO, CA, United States 92121
- Phone
- 858-263-4333
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- David Johnson
- President, Interim Chief Financial Officer, Interim Treasurer, Executive Director
- Cam Gallagher
- Chief Executive Officer, Director
- Kimberly Blackwell
- Chief Scientific Officer
- Mark Lackner,
- Chief Medical Officer
- Diana Hausman
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $236.1M |
|---|---|
Revenue (TTM) | $40.6M |
Shares Outstanding | 71.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.72 |
EPS | $-2.75 |
Book Value | $6.18 |
P/E Ratio | -1.4x |
Price/Sales (TTM) | 5.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -543.77% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
